The most common drugs in the allergy treatment pipeline

Health insurance company Aetna has announced that it will start selling its own version of its popular drug allergy treatment, EpiPen, in 2018.The company said it will be the first in the industry to begin selling the drug, called EpiMed, for allergy sufferers and their caregivers.Aetnam will start stocking EpiPens at retail stores in the